NAFDAC Seeks Tougher Sanctions Against Peddlers of Substandard Medicines

The National Agency for Food and Drug Administration and Control, (NAFDAC), has said enforcement of more stringent penalties would drastically reduce sales and distribution of substandard and falsified (SF) medicines in the country.

The agency put the value of global commerce in sub-standards and counterfeit drugs in 2016 at $4.4 billion, accounting for 0.84 per cent of all pharmaceutical product imports globally but excluded a sizeable amount of locally produced and consumed SF medicines.  

ARISENEWS: Read More